Appeal filed against EPO sofosbuvir patent decision

10-12-2018

Appeal filed against EPO sofosbuvir patent decision

Hailshadow / iStockphoto.com

Six organisations have appealed against the European Patent Office’s (EPO) decision to uphold a patent for a key hepatitis C drug.


European Patent Office, hepatitis C, Gilead Sciences, Médecins du Monde, patent, appeal, Médecins Sans Frontières, sofosbuvir

LSIPR